Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India has informed the stock exchange that its trading window will be closed starting 1 January 2026. The closure applies to insiders, designated persons, and their immediate relatives, as required under SEBI's insider trading rules. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter and nine months ending 31 December 2025. The date of the board meeting to consider these Q3 results will be announced separately. This is a standard regulatory compliance filing and does not indicate any corporate event by itself.
No direct impact on shareholders or stock price. Insiders are restricted from trading in the company's shares during this blackout period, which is normal practice ahead of quarterly results and does not signal any positive or negative development.